Investor Type | Firm |
Type of Fund | VC |
Industries | IT (& TMT) • BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Pharmaceutical (& Medicine) |
Stages | Series B |
Investing | United States |
Investment Range | $10,000,000 - $25,000,000 |
Investment Sweet Spot | $15,000,000 |
Endeavour Vision is a venture capital firm based in Geneva, Switzerland, with an additional presence in North America. They specialize in Series B investments within various sectors, including IT & TMT, BioTech, Hardware & Manufacturing, HealthTech & Fitness, Material Science, Medical Devices & Hospital Services, Healthcare & Wellness, and Pharmaceutical & Medicine. Endeavour Vision is one of the world's largest and most experienced advisory firms focusing on medical devices, diagnostics, and digital health. Their investment strategy involves putting forward amounts ranging from $10,000,000 to $25,000,000, with a preferred 'sweet spot' of around $15,000,000 per investment. They target companies that aim to meet the most crucial unmet needs in health, particularly those that incorporate Environmental, Social, and Governance (ESG) principles into their business models. Their approach emphasizes empowering entrepreneurs to develop and commercialize technologies that modernize healthcare systems and advance patient care. With deep expertise in healthcare and therapeutic areas, Endeavour Vision combines this with knowledge of macroeconomics and both public and private markets to ensure comprehensive support for their portfolio companies. The firm operates with a strong focus on impacting the healthcare industry, advising on investments that not only promise financial returns but also deliver significant social value. Over two decades, they have cultivated an extensive network across the healthcare and financial sectors, ensuring their portfolio companies receive critical introductions and opportunities. Endeavour Vision takes pride in being true partners, aiding in commercial strategy, clinical trials, environmental policy, regulatory submissions, and asset acquisitions. They remain committed to improving the standard of care and streamlining healthcare delivery by supporting transformative technologies.